It all began 27 years ago, in a small research laboratory on the outskirts of Utrecht, when Dr. Erik Helbert — a visionary physician-scientist — dared to imagine a future where degenerative diseases could be reversed, not just managed.

With a background in molecular biology and regenerative medicine, Dr. Helbert was deeply moved by the suffering of patients with chronic conditions, many of whom had exhausted conventional treatment options. Driven by a belief that the body carries within it the tools to heal itself, he poured his personal savings into a modest laboratory equipped with little more than passion, a microscope, and an unwavering mission.

From these humble beginnings, the company was born — with one goal: to make cell-based therapies safe, accessible, and scientifically sound. What started as a one-man effort has since grown into a world-renowned biotech organization based in the Netherlands, with state-of-the-art GMP-certified manufacturing facilities, dozens of breakthrough patents, and a global network of clinical partners and research collaborators.

Today, our company stands as a pillar of innovation in the fields of stem cells, exosome technology, PRP systems, and next-generation regenerative solutions. We proudly support hospitals, fertility clinics, dermatologists, and research centers across more than 40 countries.

Beyond our scientific achievements, we remain committed to our founding values: patient-centered care, evidence-driven science, and ethical innovation. Every vial we produce, every protocol we design, and every partnership we form is a tribute to the vision Dr. Helbert set in motion nearly three decades ago — a vision to heal, restore, and elevate human life through the limitless power of biology.